Five-year colonoscopy follow-up matched three-year for cancer risk in large European trial

A large population study using NADMED's redox metabolite testing platform has established healthy reference ranges for NAD and glutathione, two key drivers of cellular energy metabolism, and identified distinct disease-related alterations in both from a single blood sample.

Researchers at the University of Gothenburg have developed a treatment for acute myeloid leukemia that forces cancer cells to run at full throttle while cutting off their energy supply, driving them to burn out and die from the stress. The first study in mice shows highly promising results.

Ada Yonath, the 2009 Nobel laureate in Chemistry, died on August 31, 2026, at the age of 87. She was one of the first Nobel Prize laureates I interviewed as a new editor at Nordic Life Science – and the first I met in person, over an interview at the Grand Hotel in Stockholm. Yonath, who in 2009 became the first woman in 45 years to win the Nobel Prize in Chemistry, spoke to me about her curiosity, polar bears, extremely durable bacteria from the Black Sea, and her passion for science.

A study co-authored by a researcher with ties to Sweden's Linköping University and University of Gothenburg has won the 2026 Ig Nobel Prize for Olfaction, awarded at the 36th First Annual Ig Nobel Prize ceremony – the first held outside the US in the prize's 35-year history.

Researchers at the University of Turku, working with France's Gustave Roussy Institute, have identified a molecular mechanism that lets an aggressive subtype of colorectal cancer shield itself from chemotherapy and spread through the abdominal cavity – and shown that antibodies already used against other cancers can disrupt the process.

The Lundbeck Foundation has awarded DKK 78 million to a pan-Nordic centre that will focus on research into the glymphatic system.

From August 18-24, 2026, patients, physicians, caregivers, and supporters from around the world will embark on a six-day cycling expedition across Iceland with the purpose of accelerating research into multiple myeloma.